Post by Scripps Research

In this week's Front Row lecture, President and CEO Peter Schultz will highlight the progress Scripps Research has made in pioneering a new model for non-profit biomedical research. He will describe how integrating basic science and translational research under one roof is accelerating next-generation medicines—from new immunotherapies for cancer and innovative medicines for infectious disease to regenerative treatments for heart, lung, and intestinal tissues. At a time of uncertainty in federal science funding, this model is not only advancing human health but also helping to generate sustainable support for innovative scientific research and for training the next generation of scientific leaders. 🔬🌟 Join us for “Advancing the vision: An experiment in rethinking the nonprofit biomedical research model” 📅 Wednesday, April 22, 2026 ⏰ 4:00 p.m. PT | 7:00 p.m. ET 🎟️ Free and open to the public 📍Attend in person or virtually 🔗 Register now: https://ow.ly/Nu6V50YN0vr